card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Evaluation and Reproducibility Study using NanoString GeoMx Immune Pathway Panel

Home / Insights / Evaluation and Reproducibility Study using NanoString GeoMx Immune Pathway Panel

The rapidly advancing field of spatial biology has led to development of new platforms which provide measurements of gene and protein expression and their precise localization to defined tissue regions.  The NanoStringGeoMxDSP (digital spatial profiling) platform enables spatial profiling using formalin-fixed, paraffin-embedded (FFPE) tumor biopsy samples with a read out using either the nCounteror next generation sequencing.  In this study, IQVIA Laboratories evaluated both healthy tonsil sections and a well characterized breast carcinoma biopsy in a proof-of-concept study examining variability across days, patient biopsies and sample stability.

 

Complete the form below to access this scientific poster and explore the methods, results, and conclusions of this study.